News
-
-
PRESS RELEASE
Public Health Vaccines Announces Initiation of First Clinical Trial Evaluating Its Marburg Virus Vaccine
Public Health Vaccines, LLC initiates Phase 1 clinical trial for single-dose vaccine against Marburg virus, with BARDA funding up to $72 million for development. Company aims for global preparedness against infectious diseases